Nuveen’s PetMed Express PETS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-45,818
Closed -$219K 3396
2024
Q1
$219K Sell
45,818
-14,269
-24% -$83K ﹤0.01% 3167
2023
Q4
$454K Buy
60,087
+520
+0.9% +$4.27K ﹤0.01% 3039
2023
Q3
$611K Sell
59,567
-107
-0.2% -$1.32K ﹤0.01% 2776
2023
Q2
$823K Hold
59,674
﹤0.01% 2740
2023
Q1
$969K Sell
59,674
-1,373
-2% -$25.9K ﹤0.01% 2622
2022
Q4
$1.08M Sell
61,047
-4,034
-6% -$80.1K ﹤0.01% 2654
2022
Q3
$1.27M Sell
65,081
-107
-0.2% -$2.27K ﹤0.01% 2641
2022
Q2
$1.3M Sell
65,188
-1,160
-2% -$25.9K ﹤0.01% 2675
2022
Q1
$1.83M Buy
66,348
+740
+1% +$19.2K ﹤0.01% 2542
2021
Q4
$1.69M Sell
65,608
-5,182
-7% -$143K ﹤0.01% 2647
2021
Q3
$1.9M Sell
70,790
-3,506
-5% -$101K ﹤0.01% 2691
2021
Q2
$2.37M Sell
74,296
-2,101
-3% -$66.7K ﹤0.01% 2627
2021
Q1
$2.69M Sell
76,397
-161
-0.2% -$5.6K ﹤0.01% 2469
2020
Q4
$2.45M Buy
76,558
+228
+0.3% +$7.03K ﹤0.01% 2409
2020
Q3
$2.41M Sell
76,330
-2,099
-3% -$69.5K ﹤0.01% 2289
2020
Q2
$2.79M Buy
78,429
+555
+0.7% +$19.3K ﹤0.01% 2192
2020
Q1
$2.24M Buy
77,874
+1,296
+2% +$34K ﹤0.01% 2135
2019
Q4
$1.8M Sell
76,578
-2,857
-4% -$64K ﹤0.01% 2464
2019
Q3
$1.43M Sell
79,435
-4,304
-5% -$71.1K ﹤0.01% 2545
2019
Q2
$1.31M Buy
+83,739
New +$1.65M ﹤0.01% 2626

Other funds holding PETS

Nuveen's PETS Position: Q2 2024 in Review

Nuveen sold out of PetMed Express (PETS) in Q2 2024, closing a stake of 45,818 shares — an estimated $219K sold.

Nuveen first reported a position in PETS in Q2 2019 and held it in 20 quarters. The position peaked at $2.79M in Q2 2020. 117 funds tracked by Wall St. Rank hold PETS as of Q2 2024.

  • Nuveen reported no remaining PetMed Express position as of Q2 2024 after selling out during the quarter.
  • Nuveen sold 45,818 PetMed Express shares in Q2 2024, an estimated $219K.
  • Nuveen first reported a position in PetMed Express in Q2 2019 and held it in 20 quarters.
  • Nuveen's PetMed Express position peaked at $2.79M in Q2 2020.
  • 117 funds tracked by Wall St. Rank held PetMed Express as of Q2 2024.

Based on Nuveen's 13F filing for Q2 2024, filed 9 Aug 2024.